RG
LH icon

Redmile Group’s Labcorp LH Stock Holding History

Redmile Group’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-335,698
Closed -$51.8M – 92
2018
Q2 		$51.8M Buy
+335,698
New +$50.7M 1.76% 21

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Redmile Group's LH Position: Q3 2018 in Review

Redmile Group sold out of Labcorp (LH) in Q3 2018, closing a stake of 335,698 shares — an estimated $51.8M sold.

Redmile Group first reported a position in LH in Q2 2018 and held it in 1 quarter. The position peaked at $51.8M in Q2 2018. 794 funds tracked by Wall St. Rank hold LH as of Q3 2018.

  • Redmile Group reported no remaining Labcorp position as of Q3 2018 after selling out during the quarter.
  • Redmile Group sold 335,698 Labcorp shares in Q3 2018, an estimated $51.8M.
  • Redmile Group first reported a position in Labcorp in Q2 2018 and held it in 1 quarter.
  • Redmile Group's Labcorp position peaked at $51.8M in Q2 2018.
  • 794 funds tracked by Wall St. Rank held Labcorp as of Q3 2018.

Based on Redmile Group's 13F filing for Q3 2018, filed 14 Nov 2018.